Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 976 AL 990

Disorders of Taste and Smell

DeVere R.

Continuum (Minneap Minn). 2017 Apr;23(2, Selected Topics in Outpatient Neurology):421-446. doi: 10.1212/CON.0000000000000463.

The "DOC" screen: Feasible and valid screening for depression, Obstructive Sleep Apnea (OSA) and cognitive impairment in stroke prevention clinics

Swartz RH, Cayley ML, Lanctôt KL, Murray BJ, Cohen A, Thorpe KE, Sicard MN, Lien K, Sahlas DJ, Herrmann N.

PLoS One. 2017 Apr 4;12(4):e0174451. doi: 10.1371/journal.pone.0174451. eCollection 2017.

Neuroversion: using electroconvulsive therapy as a bridge to deep brain stimulation implantation

Williams NR, Sahlem G, Pannu J, Takacs I, Short B, Revuelta G, George MS.

Neurocase. 2017 Feb;23(1):26-30. doi: 10.1080/13554794.2016.1276605. Epub 2017 Feb 7.

Magnetic resonance imaging for the diagnosis of Parkinson's disease

Heim B, Krismer F, De Marzi R, Seppi K.

J Neural Transm (Vienna). 2017 Aug;124(8):915-964. doi: 10.1007/s00702-017-1717-8. Epub 2017 Apr 4.

Multiple System Atrophy - State of the Art

Laurens B, Vergnet S, Lopez MC, Foubert-Samier A, Tison F, Fernagut PO, Meissner WG.

Curr Neurol Neurosci Rep. 2017 May;17(5):41. doi: 10.1007/s11910-017-0751-0.

Response of the cerebral vasculature following traumatic brain injury

Salehi A, Zhang JH, Obenaus A.

J Cereb Blood Flow Metab. 2017 Jul;37(7):2320-2339. doi: 10.1177/0271678X17701460. Epub 2017 Apr 5.

Nigrostriatal interaction in the aging brain: new therapeutic target for Parkinson's disease

Błaszczyk JW.

Acta Neurobiol Exp (Wars). 2017;77(1):106-112. doi: 10.21307/ane-2017-041.

Parkinson's disease and occupational exposures: a systematic literature review and meta-analyses

Gunnarsson LG, Bodin L.

Scand J Work Environ Health. 2017 May 1;43(3):197-209. doi: 10.5271/sjweh.3641. Epub 2017 Apr 5.

Back to the future: 30th anniversary of deep brain stimulation for Parkinson's disease

Pozzi NG, Pacchetti C.

Funct Neurol. 2017 Jan/Mar;32(1):5-6. doi: 10.11138/fneur/2017.32.1.005.

The Contribution of Necroptosis in Neurodegenerative Diseases

Shao L, Yu S, Ji W, Li H, Gao Y.

Neurochem Res. 2017 Aug;42(8):2117-2126. doi: 10.1007/s11064-017-2249-1. Epub 2017 Apr 5.

Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis

Wilby KJ, Johnson EG, Johnson HE, Ensom MHH.

Ann Pharmacother. 2017 Aug;51(8):682-695. doi: 10.1177/1060028017703992. Epub 2017 Apr 6.

Influence of a removable prosthesis on oral health-related quality of life and mastication in elders with Parkinson disease

Ribeiro GR, Campos CH, Rodrigues Garcia RCM.

J Prosthet Dent. 2017 Nov;118(5):637-642. doi: 10.1016/j.prosdent.2016.12.018. Epub 2017 Apr 3.

NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis

Liu H, Liu H, Li T, Cui J, Fu Y, Ren J, Sun X, Jiang P, Yu S, Li C.

Neurosci Lett. 2017 May 22;650:25-32. doi: 10.1016/j.neulet.2017.01.062. Epub 2017 Apr 4.

Microbial Immuno-Communication in Neurodegenerative Diseases

Main BS, Minter MR.

Front Neurosci. 2017 Mar 23;11:151. doi: 10.3389/fnins.2017.00151. eCollection 2017.

A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease

Song L, Xu MB, Zhou XL, Zhang DP, Zhang SL, Zheng GQ.

Oxid Med Cell Longev. 2017;2017:2163053. doi: 10.1155/2017/2163053. Epub 2017 Mar 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias